From: An updated overview of Juvenile systemic sclerosis in a French cohort
Demographic characteristics | Clinical presentation | ||
---|---|---|---|
Sex | Cutaneous involvement | 18/18 (100) | |
Female | 16 (89) | RP | 13 (72) |
Male | 2 (11) | Skin induration | 15 (83) |
F/M ratio | 8:1 | Scleroderma proximal to MCP | 10 (56) |
Familial history of AI disease (n = 16) | 5 (31) | Digital ulcerations | 13 (72) |
1st degree | 3 (19) | Nailfold changes | 13 (72) |
2nd degree | 2 (11) | Telangiectasia | 9 (50) |
Age at diagnosis (years) | Livedo | 5 (28) | |
Median | 10 | Calcinosis | 4 (22) |
Range | 4–15 | Chilblain | 3 (17) |
Duration of symptoms before diag. (months) | Digital infarction | 2 (11) | |
Median | 9 | Articular involvement | 8/18 (44) |
Range | 1–24 | Synovitis | 5 (28) |
Duration of follow-up (years) | Arthritis | 4 (22) | |
Median | 4,5 | Tendinous retraction | 4 (22) |
Clinical presentation | Muscular involvement | 3/18 (17) | |
Limited | 10 (56) | Gastro-intestinal involvement | 14/18 (78) |
Diffuse | 8 (44) | Abdominal pain | 9 (50) |
Overlap syndromes | 5 (28) | Pyrosis / reflux | 8 (44) |
DM | 4 (22) | Diarrhea | 3 (17) |
Lupus | 2 (11) | Vomiting | 2 (11) |
Sjögren | 1 (6) | Digestive occlusion | 1 (6) |
Esophagal dysmotility | 6 (33) | ||
Pulmonary involvement | 14/18 (78) | ||
Dyspnea | 12 (67) | ||
Intersitial lung disease | 7 (39) | ||
Restrictive lung disease | 10 (56) | ||
Low CO-transfer | 9 (50) | ||
Pulmonary arterial hypertension | 1 (6) | ||
Cardiac involvement | 6/18 (33) | ||
Pericarditis | 3 (17) | ||
Myocarditis | 2 (11) | ||
Renal crisis | 0/18 |